Learn More
Medchemexpress LLC Dbco-peg4-ggfg-dxd | 2694856-51-2 | 98.4% | 1375.45 | C72H79FN10O17 | 25 MG

Supplier: Medchemexpress LLC HY13472325MG
Dbco-peg4-ggfg-dxd is a click-reactive drug-linker conjugate for research use in antibody-drug conjugate (ADC) development. It contains a DBCO group for strain-promoted alkyne-azide cycloaddition to enable conjugation to azide-functionalized antibodies or biomolecules, a PEG4 spacer for solubility, a GGFG peptide linker, and a DXd topoisomerase I inhibitor payload.
- Contains a DBCO click-reactive group for SPAAC conjugation.
- Includes a PEG4 spacer to improve solubility and flexibility.
- Features a GGFG peptide linker designed for cleavable release.
- Delivers the DXd topoisomerase I inhibitor payload for cytotoxic activity.
- Provided in small-milligram quantities suitable for research and ADC construction.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.